Literature DB >> 14564229

New concepts in post-infarction ventricular remodeling.

James E Udelson1, Richard D Patten, Marvin A Konstam.   

Abstract

An understanding of the process of left ventricular (LV) remodeling has led to greater knowledge of the pathophysiology of heart failure syndrome. This article examines the relationship between LV remodeling and clinical outcomes of heart failure syndrome from several different perspectives. The studies cited suggest that the post-myocardial infarction process is related to and associated with long-term progression of LV dysfunction, heart failure symptoms, and mortality. It is also demonstrated that drug therapies that slow or reverse the remodeling process appear to have favorable natural history effects in the short term as well as during long-term therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14564229

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  11 in total

Review 1.  Cell therapy for left ventricular remodeling.

Authors:  Doris A Taylor; Andrey G Zenovich
Journal:  Curr Heart Fail Rep       Date:  2007-03

2.  Peri-infarct pacing with CRT in the early postinfarct phase to attenuate long-term remodeling.

Authors:  Eugene S Chung; Wojciech Mazur; Santosh G Menon; Edward J Schloss; Theodore Chow; Dean J Kereiakes
Journal:  J Cardiovasc Transl Res       Date:  2008-09-26       Impact factor: 4.132

3.  The dynamic change of TGF-beta1 in the myocardial remodeling of rat after myocardial infarction.

Authors:  Zhangqiang Guo; Yuhua Liao; Xiang Cheng; Bin Li; Ying Liu; Hongxia Ge; Ling Zhang; Min Wang; Heping Guo
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

4.  17 Beta-estradiol differentially affects left ventricular and cardiomyocyte hypertrophy following myocardial infarction and pressure overload.

Authors:  Richard D Patten; Isaac Pourati; Mark J Aronovitz; Alawi Alsheikh-Ali; Sarah Eder; Thomas Force; Michael E Mendelsohn; Richard H Karas
Journal:  J Card Fail       Date:  2008-04       Impact factor: 5.712

Review 5.  Atherosclerosis as a disease of failed endogenous repair.

Authors:  Andrey G Zenovich; Doris A Taylor
Journal:  Front Biosci       Date:  2008-05-01

6.  Equilibrium radionuclide angiography for evaluating the effect of percutaneous coronary intervention on ventricular aneurysm formation and systolic synchrony in patients with acute myocardial infarction.

Authors:  Xue Ling; Fu Xiang-Hua; Liu Jun; Jia Xin-Wei; Wu Wei-Li; Gu Xin-Shun; Ding Chao; Jiang Yun-Fa; Hao Guo-Zhen; Fan Wei-Ze; Zhang Jing
Journal:  Int J Cardiovasc Imaging       Date:  2009-08-12       Impact factor: 2.357

7.  Survival benefit of ghrelin in the heart failure due to dilated cardiomyopathy.

Authors:  Cheng-Kun Du; Dong-Yun Zhan; Sachio Morimoto; Tsuyoshi Akiyama; Daryl O Schwenke; Hiroshi Hosoda; Kenji Kangawa; Mikiyasu Shirai
Journal:  Pharmacol Res Perspect       Date:  2014-08-24

8.  Effects of buyang huanwu decoction on ventricular remodeling and differential protein profile in a rat model of myocardial infarction.

Authors:  Ying Chun Zhou; Bin Liu; Ying Jia Li; Lin Lin Jing; Ge Wen; Jing Tang; Xin Xu; Zhi Ping Lv; Xue Gang Sun
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-19       Impact factor: 2.629

9.  Analysis of apical remodeling in gated myocardial perfusion SPECT imaging in ischemic cardiomyopathy.

Authors:  Guillermo Romero-Farina; Jaume Candell-Riera; Santiago Aguadé-Bruix; Joan Castell-Conesa; Gustavo de León
Journal:  J Nucl Cardiol       Date:  2008 Mar-Apr       Impact factor: 3.872

10.  Cardioprotection by an anti-MASP-2 antibody in a murine model of myocardial infarction.

Authors:  James E Clark; Thomas Dudler; Michael S Marber; Wilhelm Schwaeble
Journal:  Open Heart       Date:  2018-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.